News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
GILLIS STEVEN
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2023 |
4
| ARCH Venture Partners XII, LLC (10% Owner) has filed a Form 4 on Neumora Therapeutics, Inc.|
Txns:
| Bought 34,000 shares
@ $11.73, valued at
$398.8k
Bought 24,504 shares
@ $12.31, valued at
$301.6k
|
|
| 08/10/2023 |
4
| ARCH Venture Fund XI, L.P. (10% Owner) has filed a Form 4 on DA32 Life Science Tech Acquisition Corp.|
Txns:
| Disposed of 1,600,000 shares
@ $0 |
|
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2023 |
4
| GILLIS STEVEN (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 23,000 options to buy
@ $1.03, valued at
$23.7k
|
|
| 01/30/2023 |
4
| GILLIS STEVEN (Director) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Granted 75,000 options to buy
@ $0.575, valued at
$43.1k
|
|
| 10/26/2022 |
4
| ARCH Venture Partners X, LLC (10% Owner) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Converted 5,728,297 shares
@ $0
Converted 5,728,297 shares
@ $0
Bought 400,000 shares
@ $17, valued at
$6.8M
Converted 16,666,667 convertible preferred
@ $0
Converted 16,666,664 convertible preferred
@ $0
Converted 1,141,474 convertible preferred
@ $0
Converted 1,141,474 convertible preferred
@ $0 |
|
| 10/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/15/2022 |
4
| GILLIS STEVEN (Director) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Bought 5,000,000 shares
@ $0
Bought 5,000,000 warrants
@ $1.875, valued at
$9.4M
|
|
| 06/21/2022 |
4
| GILLIS STEVEN (Director) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 7,500 options to buy
@ $2.83, valued at
$21.2k
Granted 1,500 restricted stock units
@ $0 |
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2022 |
4
| GILLIS STEVEN (Director) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 8,750 restricted stock units
@ $0 |
|
| 01/31/2022 |
4
| GILLIS STEVEN (Director) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Granted 100,000 options to buy
@ $1.53, valued at
$153k
|
|
| 08/09/2021 |
4
| ARCH Venture Fund XI, L.P. (10% Owner) has filed a Form 4 on DA32 Life Science Tech Acquisition Corp.|
Txns:
| Disposed of 701,250 options to buy
@ $0 |
|
| 08/03/2021 |
4
| ARCH Venture Fund XI, L.P. (10% Owner) has filed a Form 4 on DA32 Life Science Tech Acquisition Corp.|
Txns:
| Bought 1,600,000 shares
@ $10, valued at
$16M
Acquired 650,000 shares
@ $10, valued at
$6.5M
|
|
| 07/27/2021 |
3
| ARCH Venture Fund XI, L.P. (10% Owner) has filed a Form 3 on DA32 Life Science Tech Acquisition Corp. |
| 07/20/2021 |
4
| ARCH Venture Partners X, LLC (10% Owner) has filed a Form 4 on Erasca, Inc.|
Txns:
| Converted 5,527,777 shares
@ $0
Converted 2,100,000 preferred shares
@ $0
Converted 3,400,000 preferred shares
@ $0
Converted 1,133,333 preferred shares
@ $0 |
|
| 07/15/2021 |
3
| ARCH Venture Partners X, LLC (10% Owner) has filed a Form 3 on Erasca, Inc. |
| 06/23/2021 |
4
| ARCH Venture Partners X, LLC (10% Owner) has filed a Form 4 on Verve Therapeutics, Inc.|
Txns:
| Converted 1,254,404 shares
@ $0
Converted 1,254,405 shares
@ $0
Converted 7,107,024 convertible preferred
@ $0
Converted 7,107,023 convertible preferred
@ $0
Converted 4,508,144 convertible preferred
@ $0
Converted 4,508,146 convertible preferred
@ $0 |
|
| 06/22/2021 |
4
| GILLIS STEVEN (Director) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 10,000 options to buy
@ $24.13, valued at
$241.3k
|
|
| 06/22/2021 |
4
| GILLIS STEVEN (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 18,000 options to buy
@ $7.26, valued at
$130.7k
|
|
| 06/16/2021 |
3
| ARCH Venture Fund X, L.P. (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 02/10/2021 |
4
| ARCH Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Sana Biotechnology, Inc.|
Txns:
| Converted 10,156,250 shares
@ $0
Converted 10,156,250 shares
@ $0
Converted 11,718,750 shares
@ $0
Converted 11,718,750 shares
@ $0
Converted 3,687,500 convertible preferred
@ $0
Converted 3,687,500 convertible preferred
@ $0
Converted 5,687,500 convertible preferred
@ $0
Converted 9,375,000 convertible preferred
@ $0
Converted 9,375,000 convertible preferred
@ $0
Converted 5,687,500 convertible preferred
@ $0
Converted 781,250 convertible preferred
@ $0 |
|
| 02/03/2021 |
3
| ARCH Venture Fund X, L.P. (10% Owner) has filed a Form 3 on Sana Biotechnology, Inc. |
| 01/29/2021 |
4
| GILLIS STEVEN (Director) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Granted 100,000 options to buy
@ $3.15, valued at
$315k
|
|
| 10/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/01/2020 |
4
| GILLIS STEVEN (Director) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Disposed/sold 1,771 options to buy
@ $0
Granted 1,771 options to buy
@ $118, valued at
$209k
Disposed/sold 111 options to buy
@ $0
Granted 111 options to buy
@ $110, valued at
$12.2k
Disposed/sold 880 options to buy
@ $0
Granted 880 options to buy
@ $28, valued at
$24.6k
Disposed/sold 440 options to buy
@ $0
Granted 440 options to buy
@ $27.8, valued at
$12.2k
Disposed/sold 12,400 options to buy
@ $0
Granted 12,400 options to buy
@ $4.68, valued at
$58k
Disposed/sold 15,000 options to buy
@ $1.06, valued at
$15.9k
|
|
| 06/12/2020 |
4
| GILLIS STEVEN (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 18,000 options to buy
@ $16.32, valued at
$293.8k
|
|
| 04/06/2020 |
4
| GILLIS STEVEN (Director) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Granted 10,000 options to buy
@ $1.28, valued at
$12.8k
|
|
| 01/24/2020 |
4
| GILLIS STEVEN (Director) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Granted 350,000 options to buy
@ $1.46, valued at
$511k
|
|
| 01/13/2020 |
4
| GILLIS STEVEN (Director) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.54, valued at
$23.1k
|
|
|
|
|